A detailed history of Vanguard Group Inc transactions in Inogen Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,424,026 shares of INGN stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,424,026
Previous 1,358,072 4.86%
Holding current value
$11.6 Million
Previous $7.46 Million 54.14%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$5.26 - $10.15 $346,918 - $669,433
65,954 Added 4.86%
1,424,026 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$4.21 - $6.32 $22,304 - $33,483
5,298 Added 0.39%
1,358,072 $7.46 Million
Q3 2023

Nov 14, 2023

SELL
$5.14 - $11.28 $654,270 - $1.44 Million
-127,290 Reduced 8.6%
1,352,774 $7.06 Million
Q2 2023

Aug 14, 2023

SELL
$10.01 - $13.86 $7.76 Million - $10.7 Million
-775,326 Reduced 34.38%
1,480,064 $17.1 Million
Q1 2023

May 15, 2023

SELL
$11.88 - $26.0 $5.22 Million - $11.4 Million
-439,070 Reduced 16.3%
2,255,390 $28.1 Million
Q4 2022

Feb 10, 2023

BUY
$19.14 - $24.55 $1.62 Million - $2.08 Million
84,722 Added 3.25%
2,694,460 $53.1 Million
Q3 2022

Nov 14, 2022

SELL
$22.74 - $31.8 $408,137 - $570,746
-17,948 Reduced 0.68%
2,609,738 $63.4 Million
Q2 2022

Aug 12, 2022

BUY
$22.88 - $35.28 $1.43 Million - $2.21 Million
62,672 Added 2.44%
2,627,686 $63.5 Million
Q1 2022

May 13, 2022

BUY
$28.1 - $35.25 $1.2 Million - $1.51 Million
42,755 Added 1.7%
2,565,014 $83.2 Million
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $1.57 Million - $2.33 Million
52,909 Added 2.14%
2,522,259 $85.8 Million
Q3 2021

Nov 12, 2021

BUY
$43.09 - $82.26 $5.08 Million - $9.7 Million
117,932 Added 5.02%
2,469,350 $106 Million
Q2 2021

Aug 13, 2021

BUY
$52.03 - $68.77 $122 Million - $162 Million
2,351,418 New
2,351,418 $153 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $186M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.